LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million ...

BALTIMORE, Md.--DNA Bactofection, a novel technology for introducing genes into cells using live, attenuated invasive bacterial vectors, has been licensed to Microscience Ltd. by the University System ...

A British company developing a vaccine for "Delhi belly" hopes to raise £40m next month when it becomes the latest British biotechnology firm to brave flotation. Microscience, with several drugs in ...

The event is organized by the UK-based Royal Microscopical Society (RMS), and will open with a plenary lecture from Sir David King, who was science and technology advisor to the UK government from ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Microscience, London, raised $36.4 million in third-round funding. The investment was led by Advent Venture Partners, J.P. Morgan Partners, Apax Partners Funds, and Merlin Biosciences. The company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...

FLOTATION of a Wokingham-based biotechnology company will net £10m for its management and founders, including five London doctors. Microscience intends to float on Aim next month, raising £40m of new ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

LONDON - Microscience Ltd. is looking to raise £40 million (US$71.6 million) in an initial public offering on London's Alternative Investment Market to finance development of five vaccines in clinical ...